Annual report [Section 13 and 15(d), not S-K Item 405]

Common Stock (Details Narrative)

v3.26.1
Common Stock (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 28, 2025
Sep. 12, 2025
Jul. 01, 2020
Sep. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Jun. 27, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Capital stock, shares authorized           101,000,000   155,000,000
Common stock, shares authorized           100,000,000 150,000,000 150,000,000
Preferred stock, shares authorized           1,000,000   5,000,000
Common stock, par value           $ 0.001 $ 0.001  
Common stock, shares issued           13,784,000 10,174,000  
Common stock, shares outstanding           13,784,000 10,174,000  
Common stock, voting rights           The holders of common stock are entitled to one vote for each share of common stock held.    
Net proceeds of common stock           $ 154,000  
Warrants outstanding           7,222,821 0  
At-The-Market Offering Agreement [Member] | Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Value of shares available for sale     $ 10,000,000          
Number of shares sold   1,200,152   85,076 85,076      
Average share price       $ 1.88 $ 1.88      
Net proceeds of common stock   $ 2,380,000            
Securities Purchase Agreement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of shares sold 743,024 2,764,710            
Unit price per share $ 1.39              
Warrants exercise price $ 1.24              
Warrant expiration period 27 months              
Gross proceeds $ 1,032,000              
Share per price   $ 1.70            
Proceeds from sale of common shares and warrants   $ 4,183,000            
Securities Purchase Agreement [Member] | Investor Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercise price   $ 1.50            
Warrant issued to purchase of common stock   5,529,420            
Securities Purchase Agreement [Member] | Placement Agent Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercise price   $ 2.125            
Warrant issued to purchase of common stock   207,353            
Fee payment description   The Company paid Wainwright consideration consisting of (i) a cash fee equal to 7.0% of the aggregate gross proceeds in the offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds in the offering, (iii) reimbursement of certain expenses and (iv) warrants to acquire up to an aggregate of 207,353 shares of common stock (the “Placement Agent Warrants”)